 |
| Quantity: | |
|---|---|
Specifications:
It usually exists as a white to off - white powder in its solid form, which is a common physical state for many peptide - based drugs.
Identification of semaglutide can be achieved through advanced analytical techniques. High - performance liquid chromatography (HPLC) is often used to analyze its purity and molecular characteristics. Additionally, mass spectrometry (MS) can accurately determine its molecular weight and confirm its chemical structure by analyzing the fragmentation patterns of the peptide molecule.
Purity: High purity is a crucial requirement, typically with a purity level of 95% or higher. Impurities in semaglutide could potentially affect its safety and efficacy, so strict control over purity is necessary.
Related Substances: Limits are set for related substances, which are impurities closely related to the structure of semaglutide. The total amount of related substances is usually required to be less than a specific percentage, such as 3 - 5%, to ensure the quality and consistency of the drug.
Water Content: The water content in the powder form is carefully monitored and is usually required to be within a certain range, for example, less than 1.0%, to maintain the stability of the peptide structure.
Residual Solvents: As it is synthesized through chemical processes, the levels of residual solvents used in production are strictly regulated to meet safety standards for human use.
Semaglutide is mainly used for the treatment of type 2 diabetes mellitus. It works by mimicking the actions of GLP - 1, which can stimulate insulin secretion in a glucose - dependent manner, suppress glucagon secretion, slow down gastric emptying, and reduce appetite, thereby helping to control blood glucose levels and also contributing to weight loss in many patients. It is available in both injectable and oral formulations, providing more convenient treatment options for patients.